These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38393147)

  • 1. Short-Term Effects of Botulinum Toxin-A Injection on the Medial Gastrocnemius Histological Features in Ambulant Children with Cerebral Palsy: A Longitudinal Pilot Study.
    Deschrevel J; Andries A; Maes K; De Beukelaer N; Corvelyn M; Staut L; De Houwer H; Costamagna D; Desloovere K; Van Campenhout A; Gayan-Ramirez G
    Toxins (Basel); 2024 Jan; 16(2):. PubMed ID: 38393147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
    De Beukelaer N; Weide G; Huyghe E; Vandekerckhove I; Hanssen B; Peeters N; Uytterhoeven J; Deschrevel J; Maes K; Corvelyn M; Costamagna D; Gayan-Ramirez G; Van Campenhout A; Desloovere K
    Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological analysis of the gastrocnemius muscle in preschool and school age children with cerebral palsy compared with age-matched typically developing children.
    Deschrevel J; Andries A; Maes K; Peeters J; van Opstal A; Jiang D; De Beukelaer N; Corvelyn M; Staut L; De Houwer H; Costamagna D; Desloovere K; Van Campenhout A; Gayan-Ramirez G
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C573-C588. PubMed ID: 38105751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
    Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
    Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.
    Peeters N; Papageorgiou E; Hanssen B; De Beukelaer N; Staut L; Degelaen M; Van den Broeck C; Calders P; Feys H; Van Campenhout A; Desloovere K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection.
    Dağ N; Cerit MN; Şendur HN; Zinnuroğlu M; Muşmal BN; Cindil E; Oktar SÖ
    J Med Ultrason (2001); 2020 Oct; 47(4):609-615. PubMed ID: 32705628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E; Peeters N; Staut L; Molenaers G; Ortibus E; Van Campenhout A; Desloovere K
    Eur J Paediatr Neurol; 2024 Mar; 49():131-140. PubMed ID: 38518417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI changes in calf muscles of two children with cerebral palsy following Botulinum Toxin Type A injections: a preliminary report.
    de Coulon G; Canavese F; Armand S; Bonnefoy-Mazure A; Merlini L
    J Pediatr Orthop B; 2022 Jan; 31(1):e81-e84. PubMed ID: 33038149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
    Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
    Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.